New hope for kids with rare cancer: modified treatment trial aims to boost survival
NCT ID NCT04881838
Summary
This study is testing a modified version of a standard chemotherapy regimen (ALCL99) for Chinese children and adolescents newly diagnosed with a high-risk type of lymphoma. The goal is to see if this adapted treatment plan can improve long-term survival and reduce side effects compared to past results. It will involve about 172 participants and is no longer recruiting new patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PEDIATRIC ANAPLASTIC LARGE CELL LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Shanghai Children's Medical Center
Shanghai, China
Conditions
Explore the condition pages connected to this study.